2-(11H-苯[a]咔唑)乙基氯甲酸酯柱前衍生化用于氨基酸的高效液相色谱分析

利用新型荧光试剂2-(11H-苯[a]咔唑)乙基氯甲酸酯(BCEC-Cl)作为柱前衍生化试剂,在HypersilBDS C18(200mm×4.6mm,5μm)反相色谱柱上,采用梯度洗脱对20种氨基酸衍生物进行了分离检测。在乙腈与Na2B4O7缓冲液中,室温下BCEC-Cl与氨基酸反应5min可实现完全衍生。检测的激发和发射波长分别为λex=279nm,λem=380nm。采用柱后质谱电喷雾离子源(ESI source)正离子模式,实现了水解牛血清白蛋白中氨基酸和油菜蜂花粉中氨基酸的定性定量检测。荧光定性检测的线性回归系数均大于0.9990,检出限为1.49~19.74fmol(S/N=3)。     

胆汁酸的双敏感探针苯并[b]吖啶酮-5-乙基对甲苯磺酸酯:荧光检测和APCI-MS鉴定

在HypersilC18色谱柱上,利用新型荧光试剂苯并[b]吖啶酮-5-乙基对甲苯磺酸酯(BAETS)作柱前衍生化试剂,采用梯度洗脱对10种胆汁酸衍生物进行了优化分离.在二甲亚砜溶剂中,以碳酸钾作催化剂,95℃,45min后获得稳定的荧光产物.衍生物在稳态荧光条件下,在乙腈和甲醇水溶液中的百分离子化δ值在0%～88.83%和0%～89.15%范围内.最大激发和发射波长为λex/λem=272/505nm.采用大气压化学电离源(APCI)正离子模式实现了胆汁中胆汁酸的定性定量测定.线性回归系数均在0.9995以上,线性范围宽,检出限为0.76～1.62ng/mL.     

2-(11H-苯[a]咔唑)-乙酸在脂肪胺的高效液相色谱分离及质谱鉴定中的应用

采用新型荧光衍生试剂2-(11H-苯[a]咔唑)-乙酸(BCA)进行柱前衍生并经荧光检测对脂肪胺进行高效液相色谱(HPLC)分离和质谱定性.衍生物荧光激发和发射波长为λex=285 nm,λem=384 nm.60 ℃下在乙腈溶剂中用N-乙基-N′-[(3-二甲氨基)丙基]碳二亚胺盐酸盐(EDC)作催化剂, 衍生反应15 min后获得稳定的荧光产物.在Hypersil BDS C18 (4.0 mm×200 mm, 10 μm) 色谱柱上, 采用梯度洗脱对12种脂肪胺衍生物进行了优化分离.采用大气压化学电离源(APCI Source)正离子模式进行质谱定性, 实现了各种脂肪胺衍生物的快速、准确测定.脂肪胺的线性回归系数不小于0.999 8 , 检出限(S/N=3)为5.73 ～31.3 fmol.     

柱前衍生高效液相色谱法分离分析1-氮杂双环[2,2,2]辛-3-基胺对映异构体

1-氮杂双环[2,2,2]辛-3-基胺是制备5-羟色胺拮抗剂药物盐酸帕洛诺司琼等的重要中间体,手性帕洛诺司琼可以通过中间体的手性分离来制备。用柱前衍生化-反相高效液相色谱法对1-氮杂双环[2,2,2]辛-3-基胺对映体进行分离并建立了检测方法。结果表明,用2,3,4,6-四-O-乙酰基-β-D-葡萄糖异硫氰酸酯(GITC)为柱前手性衍生化试剂,C18柱(300mm×4.6mm,5μm)为色谱柱,可将1-氮杂双环[2,2,2]辛-3-基胺对映体分离,其它色谱条件:流动相组成为[甲醇-乙腈-0.01mol/L四丁基溴化铵(20∶10∶75,V/V)]-(三乙胺)0·1%-(冰醋酸)0.15%,流速0.7mL/min,检测波长为266nm。在选择的测定条件下,衍生后的两非对映异构体分离度达4以上。     

牛血清白蛋白中氨基酸的高效液相色谱荧光测定及质谱鉴定

利用新型荧光试剂1,2苯-并-3,4二-氢咔唑-9乙-基氯甲酸酯(BCEOC)作为柱前衍生化试剂,在Hypersil BDS C18(4.6 mm×200 mm,5μm)反相色谱柱上,采用梯度洗脱对氨基酸衍生物进行了分离检测。检测的激发和发射波长分别为λex=333 nm,λem=390 nm。采用电喷雾离子源(ESI Source),实现了牛血清白蛋白中氨基酸的定性测定。荧光定量检测的线性回归系数均大于0.999;检出限为6.3~117.6 fmo。l     

脂肪胺荧光衍生物的高效液相色谱分离及质谱鉴定

采用新型荧光衍生试剂2-(9-吖啶酮)-乙酸(AAA)进行柱前衍生并经荧光检测对脂肪胺进行了高效液相色谱(HPLC)分离和在线质谱定性.衍生物荧光激发和发射波长为λex=404nm,λem=440nm.30℃下在乙腈溶剂中用N-乙基-N′-[(3-二甲氨基)丙基]碳二亚胺盐酸盐(EDC)做催化剂,衍生反应20min后获得稳定的荧光产物.在HypersilBDSC18(4.6mm×100mm,5μm)色谱柱上,采用梯度洗脱对12种脂肪胺衍生物进行了优化分离.采用大气压化学电离源(APCISource)正离子模式进行在线柱后质谱定性,实现了各种脂肪胺衍生物的快速、准确测定.该方法具有良好的重现性,多数脂肪胺的线性回归系数大于0.9996,检测限为12.09~25.52fmol.     

氮杂环荧光试剂2-(11H-苯[a]咔唑)乙基氯甲酸酯对胺类化合物标记及质谱鉴定

含氮类荧光试剂2-(11H-苯[a]咔唑)乙基氯甲酸酯(BCEC-Cl)经柱前衍生处理后,采用荧光检测及柱后在线质谱鉴定对食品中胺类化合物进行了测定。标记反应在pH9的硼酸缓冲液中进行,3min后获得稳定的荧光产物。衍生物于λex=279nm激发条件下产生强烈荧光,其发射波长在λem=380nm处。产物的分离在EclipseXDB-C8色谱柱(150mm×4.6mm,5μm)上进行,采用梯度洗脱对12种脂肪胺衍生物进行了优化分离。采用大气压化学电离源(APCISource)正离子模式进行在线的柱后质谱鉴定,实现了多种脂肪胺衍生物的快速、准确测定。建立的方法具有良好的重现性,回归系数大于0.9996,检出限为1.8~14fmol。     

Rapid Determination of Benzo[a] pyrene in Edible Vegetable Oil Using a New Type of Solid Phase Extraction Column

研究了Bond Elut ENV新型固相萃取柱在食用植物油中苯并[a]芘快速检测中的应用,建立了快速测定食用植物油样品中苯并[a]芘残留量的固相萃取/液相色谱/荧光检测法.样品用正己烷溶解,固相萃取净化,SUPELCOSILTM LC - PAH(25 cm×4.6 mm,5μm)色谱柱分离,以乙腈-水(95:5)为流动相,荧光检测(λ(n) =297 nm,λem=408 nm),外标法定量.苯并[a]芘的检出限为0.3μg/kg,在1.0 ～50.0 μg/L范围内线性关系良好,相关系数为0.9996,方法的回收率为79％～102％,相对标准偏差不高于9.4％.该方法准确、实用、简便、快速,在食用植物油的苯并[a]芘残留量检测方面有广泛的应用前景.     

高效液相色谱-质谱法分析新疆和田玫瑰花粉中脂肪酸

建立了利用苯并[b]吖啶酮-5-乙基对甲苯磺酸酯(BAETS)作为柱前荧光标记的高灵敏和高选择性的脂肪酸分析方法,并考察了该方法的分析性能。优化了34种混合脂肪酸的衍生条件,采用Hypersil BDS C8色谱柱(200×4.6mm i.d.,5μm)分离,荧光检测激发和发射波长为λex/λem=273/503nm,对脂肪酸衍生物进行定性定量分析。多数脂肪酸的线性回归系数大于0.9996,检测限在11.71~68.26fmol之间。质谱在大气压化学电离源正离子模式下,实现了玫瑰花粉中脂肪酸组分的分离分析及鉴定。方法检测限低,重现性好,对新疆和田玫瑰花粉样品的测定结果真实可靠。     

L-乙酰半胱氨酸对映体的手性荧光衍生化高效液相色谱法分析

以R-(-)/S-(+)-4-N,N-二甲基磺酰胺-7-(3-异氰酸吡咯烷)-2,1,3-苯并氧杂咪唑[R-(-)/S-DBD-PyNCS]为荧光手性衍生化试剂,用反相高效液相色谱法(RP/HPLC)对乙酰半胱氨酸(NAC)对映体进行分析。在含有1%吡啶溶液中,50℃下衍生化反应60 min,生成具有荧光特性的NAC非对映体衍生物,其结构用质谱(MS)表征。该衍生物在流动相为25 mmol/L磷酸钾缓冲溶液(pH5.9)-甲醇(体积比50∶28),流速1 mL/min时,在ODS HYPERSIL C18(200 mm×4.6 mm,5μm)色谱柱上进行分离,并在荧光检测器(λex=450nm,λem=550 nm)上检测。L-NAC在0.4~40 mg/L范围内与峰面积呈良好线性关系,回归方程为Y=2.716×104X+2.959×106,r=0.999 8,检出限(S/N=3)为0.4 ng。该方法可用于乙酰半胱氨酸制剂含量的测定。     

2-R-5-Ar(Het)-5,6-dihydro-7H-[1,2,4]triazolo[5,1-b][1,3]thiazin-7-ones

A novel method for synthesis of 2-R-5-Ar(Het)-5,6-dihydro-7H-[1,2,4]triazolo[5,1-b][1,3]thiazin-7-ones by condensation of 3-R-4,5-dihydro-1H-1,2,4-triazole-5-thiones with 3-aryl(heteryl)-2-propenoyl chlorides is proposed.     

Spectrophotometric study of the supramolecular complexes of [60]- and [70]Fullerenes with biscalix[6]arene and crown[4]calix[6]arene

[60]- and [70]Fullerenes have been shown to form 1:1 supramolecular complexes with bis[2-(5,11,17,23,29,35-hexa-tert-butyl-37,38,39,40,41-pentahydroxycalix[6]arenyl-oxy ethyl ether) (1) and 5,11,17,23,29,35-hexa-tert-butyl-37,38,40,41-tetra hydroxyl-39,42-(crown-4)calix[6]arene (2) in CHCl3 medium by electronic absorption spectroscopy. Formation constants (K) of the complexes of [60]- and [70]fullerenes with 1 and 2 have been determined at room temperature from which free energy of formation values of the complexes have been estimated. The very high formation constant value of [60]fullerene/1 complex (5900 dm3 mol-1) in indicative of formation of inclusion complex. Moreover, PM3 calculations reveal that intermolecular interaction between [60]fullerene and 1 proceeds through quite deep energy molecular orbital.     

SYNTHESIS AND ABSORPTION PROPERTIES OF SOME NEW 4-THIO-1,8-NAPHTHYLIMIDES AND 4-(THIO)-7H-BENZIMIDAZO [2,1-A] BENZ [D,E] ISOQUINOLIN-7-ONE DERIVATIVES

A series of new 1,8-naphthylimide and 4-(thio)-7H-benzimidazo[2,1-a]benz[d,e]isoquinolin-7-one derivatives has been synthesized, and the UV/Vis absorptioin characteristics discussed. Substituents' effect on the UV/Vis absorption characteristics have been investigated.     

Synthesis and Crystal Structure of 1-（4-Fluorophenyl）-2-hexylthiobenzo[4,5]-furo[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidin-5（1H）-one

The crystal structure of the title compound 1-(4-fluorophenyl) -2-hexylthio-benzo [4,5]furo[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidin-5(1H) -one(C23H21FN4O2S,Mr = 436.5) has been prepared and determined by single-crystal X-ray diffraction. The crystal is of monoclinic,space group P21/n with a = 13.9854(3) ,b = 17.2678(4) ,c = 18.1828(5) ,β = 99.364(2) °,V = 4332.58(18) 3,Z = 4,Dc = 1.338,F(000) =1824,μ = 0.185 mm-1,MoKa radiation(λ = 0.71073) ,R = 0.0538 and wR = 0.1162 for 4728 observed reflections with I > 2σ(I) . X-ray diffraction analysis reveals the fused rings of benzo[4,5]furo[3,2-d]-1,2,4-triazolo[1,5-a] pyrimidin-5(1H) -one system are nearly coplanar. The crystal packing is mainly stabilized by weak intermolecular C-H···O hydrogen bond and π-π interactions.     

相转移催化合成4-{2-[N-甲基-N-(2-吡啶基)]氨基乙氧基}苯甲醛

以2-氯吡啶(1)、2-甲氨基乙醇(2)和4-氟苯甲醛(4)为主要原料,经2步反应合成了4-{2-[N-甲基-N-(2-吡啶基)氨基乙氧基]}苯甲醛(5).第1步反应n(2)∶n(1)=4∶1,反应温度160℃,反应时间约6h,采用减压蒸馏进行后处理,2-[N-甲基-N-(2-吡啶基)氨基]乙醇(3)的收率在93％以上,过量2的回收率在97％以上,回收的2可以重复使用.第2步反应用氢氧化钠做碱性试剂,用甲苯和水分别做为两相的溶剂,在相转移催化剂CTAB作用下进行,经优化后5的收率可达90％以上.2步反应总收率达83％以上.     

[f]-Fused purine-2,6-diones: Synthesis of new [1,3,5]- and [1,3,6]-thiadiazepino-[3,2-f]-purine ring systems

Summary 6-Phenyl-1,3-dimethyl-2,4-dioxo-1,2,3,4,8,9-hexahydro-[1,3,5]-thiadiazepino-[3,2-f]-purine (5) was obtained by a three-step synthesis from 8-mercapto-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1) and 2-(benzoylamino)-ethyl chloride (2)via 8-(benzoylaminoethylthio)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (3) and its chloromido derivative4. The analogous 9-phenyl-1,3-dimethyl-2,4-dioxo-1,2,3,4,6,7-hexahydro-[1,3,6]-thiadiazepino-[3,2-f]-purine (7) was synthesized either from compound1 and N-(2-chloroethyl)-benzimido chloridevia N-(chloroethyl)-S-(1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-7H-purin-8-yl)-benzothioimide (6), or alternatively from 7-(2-benzoylaminoethyl)-8-bromo-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (9), its 8-mercapto derivative10 and the corresponding chloroimido compound11 being the intermediates.Part of this paper was presented as a preliminary report at the Congress of Czech and Slovak Chemical Societies, Olomouc, Czech Republic, September 13–16, 1993     

4H-吡啶并[3,2-e][1,3]噻嗪-4-酮嘧啶衍生物的合成

2-氯烟酸异硫氰酸酯在碱性介质中与取代2-氨基嘧啶反应直接得到4H-吡啶并[3,2-e][1,3]噻嗪-4-酮嘧啶. 所合成的6个未见文献报道的目标化合物经IR, ¹H NMR和元素分析证实了其结构, 并对反应可能机理进行了探讨.     

4-甲基-苯磺酸-2-氧-2-[3-(5-芳基-[1,3,4]噁二唑-2-基)-硫脲]-乙基酯的合成及生物活性研究

合成了12个未见文献报道的4-甲基-苯磺酸2-氧-2-[3-(5-芳基-[1,3,4]噁二唑-2-基)-硫脲]-乙基酯, 其结构经元素分析、¹H NMR和IR确证. 初步活性测试结果表明: 部分化合物有较好的杀菌活性.     

A novel synthetic route for 2-[2-（2,2,2-trifluoroethoxy）phenoxy]ethanamine

2-[2-（2,2,2-Trifluoroethoxy）phenoxy]ethanamine is the key intermediate of Silodosin, the α1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia. In order to obtain this intermediate, we developed a novel synthetic route by utilizing 2- nitrochlorobenzene as the starting material via O-alkylation, reduction, diazotization, acidolysis, etherification, condensation and hydrazinolysis. The highlight of this method lies on its convenience and economy in accessing this intermediate. 2007 Guo Hua Chert. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.     

苯并[de]蒽-7-酮类叔芳胺的合成及其发光性能的研究

芳基伯胺与芳基溴在Pd(dba)2/P(t-Bu)3催化下于80 ℃甲苯溶液中反应生成芳基仲胺, 芳基仲胺再与3-溴苯并[de]蒽-7-酮在Pd(OAc)2/P(t-Bu)3催化下于120 ℃邻二甲苯溶液中反应生成苯并[de]蒽-7-酮类叔芳胺有机电致发光材料; 3-二苯基氨基苯并[de]蒽-7-酮与丙二腈反应生成2-(3-二苯基氨基)苯并[de]蒽-7-基亚基丙二腈. 产物的结构经1H NMR, 13C NMR, 13C (DEPT), HRMS光谱所证实. 用UV-Vis, PL, DSC测定了化合物的发光性能.